Open Actively Recruiting

Fully Quantitative Low-Dose, Motion-Resolved Dynamic Contrast-Enhanced MRI in Pancreatic Adenocarcinoma (PDAC)

About

Brief Summary

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

Eligibility

Minimum Age
N/A
Maximum Age
N/A
Share:
Study Stats
Protocol No.
24-5462
Category
Pancreatic Cancer
Principal Investigator
Anthony Christodoulou
Contact
Arshia Mian
Location
  • UCLA Westwood